Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Navid Zafari"'
Autor:
Mohammad Taghi Bahreyni Toossi, navid Zafari Ghadim, Seyed Hosein Hoseini-Zarch, elham Dolat, Hosein Azimian, Majid Sadeghi Moghadam
Publikováno v:
Iranian Journal of Medical Physics, Vol 19, Iss 3, Pp 159-166 (2022)
Introduction: Cone-beam computed tomography is used for specialized imaging of dental and maxillofacial structures. CBCTs capabilities and facilities for dental and maxillofacial imaging have resulted in their increasing clinical use. Although the do
Externí odkaz:
https://doaj.org/article/f185b7e7a96c4491be76031b458d0124
Autor:
Mollaee, Parisa Fakour, Azimian, Hosein, Ghadim, Navid Zafari, Dolat, Elham, Sheykhoo, Asma, Bahreyni-Toossi, Mohammad-Taghi
Publikováno v:
Journal of Cancer Research & Therapeutics; 2023 Supplement, Vol. 19, pS737-S742, 6p
Autor:
Sonia Farhadi, Mohammad-Taghi Bahreyni-Toossi, Navid Zafari-Ghadim, Sara Khademi, Mahdi Sadat-Darbandi, Hosein Azimian
Publikováno v:
Mutation research. Genetic toxicology and environmental mutagenesis. 881
The adaptive response (AR), which can be induced by low-dose ionizing radiation (LD), may influence the therapeutic ratio of cancer treatment. We investigated the AR and the DNA double-strand break (DSB) repair pathway in human lung tumor cells and n
Autor:
Hosein Azimian, Mahdi Sadat Darbandi, Mohammad-Taghi Bahreyni-Toossi, Navid Zafari, Seyed Hamid Aghaee-Bakhtiari, Mahmoud Mahmoudi
Publikováno v:
Mutation research. 823
Purpose Radiotherapy plays a pivotal role in the treatment of cancer. One of the main challenges in this treatment modality is radiation-induced complications in some patients affected by high radiosensitivity (RS). The differences in RS are determin
Autor:
Javad Farhadi, Fereshteh Vaziri Nezamdoust, Mohammad-Taghi Bahreyni-Toossi, Hosein Azimian, Hassan Mehrad-Majd, Navid Zafari
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Introduction: Radiotherapy is a crucial component of treatment for ∼70% of all cancer patients. The identification of effective biomarkers of radiosensitivity (RS) is a fundamental goal of radiobio...
Publikováno v:
Mutation research.
Glioblastoma (GBM) is the most lethal type of primary brain tumor. Currently, even with optimal and multimodal cancer therapies, the survival rate of GBM patients remains poor. One reason for inadequate response of GBM tumors to radiotherapy is radio